Eton Pharmaceuticals Announces Acquisition of Galzin
Galzin is FDA-approved as a maintenance treatment of patients with Wilson Disease who have been initially treated with a chelating agent.
Pharmaceutical Company | 04/01/2025 | By Aishwarya
Lupin Gains Approval from FDA for Valbenazine Capsules
Lupin Ltd. has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules.
Pharmaceutical Company | 09/04/2024 | By Aishwarya | 242
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy